首页 > 最新文献

药物联合治疗最新文献

英文 中文
Clinical application of Bushen Jianpi Gutai Decoction in threatened abortion 补肾健脾固泰汤在先兆流产中的临床应用
Pub Date : 2022-01-01 DOI: 10.53388/dct2022002
Xiurong Wang, Yi-ren Liu, XiaoYing Meng, Kun Zhang, Xiaoxia Wang, WenMing Cao
{"title":"Clinical application of Bushen Jianpi Gutai Decoction in threatened abortion","authors":"Xiurong Wang, Yi-ren Liu, XiaoYing Meng, Kun Zhang, Xiaoxia Wang, WenMing Cao","doi":"10.53388/dct2022002","DOIUrl":"https://doi.org/10.53388/dct2022002","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress on the mechanism of Zuojin Pill in inhibiting cancer 左金丸抗癌作用机制的研究进展
Pub Date : 2022-01-01 DOI: 10.53388/dct2022014
Weichen Si
{"title":"Research progress on the mechanism of Zuojin Pill in inhibiting cancer","authors":"Weichen Si","doi":"10.53388/dct2022014","DOIUrl":"https://doi.org/10.53388/dct2022014","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70806295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ameliorative effect of naringenin in intoxication cases recovery 柚皮素对中毒患者康复的改善作用
Pub Date : 2021-01-01 DOI: 10.53388/dct2021110503
Said Said Elshama
{"title":"Ameliorative effect of naringenin in intoxication cases recovery","authors":"Said Said Elshama","doi":"10.53388/dct2021110503","DOIUrl":"https://doi.org/10.53388/dct2021110503","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the prescription in rules and mechanism for cerebral infarction based on data mining and Network Pharmacology 基于数据挖掘和网络药理学的脑梗死方剂规律与机制探索
Pub Date : 2021-01-01 DOI: 10.53388/dct2021080502
Bo Liu, Zixiang Kou
{"title":"Exploring the prescription in rules and mechanism for cerebral infarction based on data mining and Network Pharmacology","authors":"Bo Liu, Zixiang Kou","doi":"10.53388/dct2021080502","DOIUrl":"https://doi.org/10.53388/dct2021080502","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prediction of active ingredients and potential mechanisms of Alisma decoction against atherosclerosis: A study based on UHPLC-Q-Orbitrap-HRMS and network pharmacology 基于UHPLC-Q-Orbitrap-HRMS和网络药理学的泽泻汤有效成分预测及抗动脉粥样硬化机制研究
Pub Date : 2021-01-01 DOI: 10.53388/dct2021110504
Yiming Bi, Wei Zhang, Yigui Lai, Yingchang Fu, K. Li, Qiang Wang, Xuefeng Jiang, Hongfeng Liang, Huijie Fan
{"title":"Prediction of active ingredients and potential mechanisms of Alisma decoction against atherosclerosis: A study based on UHPLC-Q-Orbitrap-HRMS and network pharmacology","authors":"Yiming Bi, Wei Zhang, Yigui Lai, Yingchang Fu, K. Li, Qiang Wang, Xuefeng Jiang, Hongfeng Liang, Huijie Fan","doi":"10.53388/dct2021110504","DOIUrl":"https://doi.org/10.53388/dct2021110504","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential active compounds and mechanisms of Shen-Qi-Yi-Chang granule for the treatment of colorectal cancer: an analysis of network pharmacology and molecular docking 参气益肠颗粒治疗大肠癌的潜在活性成分及作用机制:网络药理学与分子对接分析
Pub Date : 2021-01-01 DOI: 10.53388/dct202108053
Jialin Gu, Jialin Yu, Ziwei Song, Guoli Wei, Yi Ji, Lingchang Li, Canhong Hu, J. Huo
{"title":"Potential active compounds and mechanisms of Shen-Qi-Yi-Chang granule for the treatment of colorectal cancer: an analysis of network pharmacology and molecular docking","authors":"Jialin Gu, Jialin Yu, Ziwei Song, Guoli Wei, Yi Ji, Lingchang Li, Canhong Hu, J. Huo","doi":"10.53388/dct202108053","DOIUrl":"https://doi.org/10.53388/dct202108053","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatoprotective and antioxidant activity of ethanolic extract of Artabotrys odoratissimus stem on rifampicin-induced hepatotoxicity in rats 香竹醇提物对利福平所致大鼠肝毒性的保护及抗氧化作用
Pub Date : 2021-01-01 DOI: 10.53388/dct2021050502
Hindustan Abdul, C. Haranath, B. Pradeepkumar, Beludari Mohammed
{"title":"Hepatoprotective and antioxidant activity of ethanolic extract of Artabotrys odoratissimus stem on rifampicin-induced hepatotoxicity in rats","authors":"Hindustan Abdul, C. Haranath, B. Pradeepkumar, Beludari Mohammed","doi":"10.53388/dct2021050502","DOIUrl":"https://doi.org/10.53388/dct2021050502","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The advantage of low-dose clomiphene citrate for overweight women with anovulation 低剂量枸橼酸克罗米芬对超重无排卵妇女的优势
Pub Date : 2021-01-01 DOI: 10.53388/dct2021050504
Pingping Sun, Na Sun, Yuemin Zhang, Jinguang Wang, Hua-Gang Ma
{"title":"The advantage of low-dose clomiphene citrate for overweight women with anovulation","authors":"Pingping Sun, Na Sun, Yuemin Zhang, Jinguang Wang, Hua-Gang Ma","doi":"10.53388/dct2021050504","DOIUrl":"https://doi.org/10.53388/dct2021050504","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective analysis of the efficacy of traditional Chinese medicine Lianhua Qingwen Capsule for the treatment of novel coronavirus-infected pneumonia 中药连花清瘟胶囊治疗新型冠状病毒感染的肺炎疗效回顾性分析
Pub Date : 2021-01-01 DOI: 10.53388/dct2021110505
Peng Chen, Xiong Gan, L. Fang, Jiexin Lei, Fuchao Chen, Yue Wu, GuoHong Pan, Benhong Zhou
{"title":"Retrospective analysis of the efficacy of traditional Chinese medicine Lianhua Qingwen Capsule for the treatment of novel coronavirus-infected pneumonia","authors":"Peng Chen, Xiong Gan, L. Fang, Jiexin Lei, Fuchao Chen, Yue Wu, GuoHong Pan, Benhong Zhou","doi":"10.53388/dct2021110505","DOIUrl":"https://doi.org/10.53388/dct2021110505","url":null,"abstract":"","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic strategy in colorectal cancer based on Traditional Chinese and Western Medicine: from the lipid metabolism perspective 基于中西医结合的结直肠癌治疗策略:从脂质代谢的角度
Pub Date : 2021-01-01 DOI: 10.53388/dct2021110501
Qian-qian Niu, Yuanhong Zhao
Colorectal cancer (CRC) is a major cause of morbidity and mortality and is closely associated with lipid metabolism, of which fatty acid metabolism, the release of fat factors and the abnormal level of blood lipids are all important pathogenic mechanisms. With the increasing awareness of lipid metabolism, advances in lipid-regulating therapy have made it possible for anti-tumor effect in CRC. However, there are still many research gaps and limitations. Given the complexity and uncertainty of targeted lipidregulating therapy for CRC, traditional Chinese medicine (TCM) may have a leg up when it comes to the theory of “holistic concept” and “treatment based on syndrome differentiation”. Meanwhile, proper dietary direction, healthy lifestyles, and normal serum lipid levels contribute directly to the prognosis of CRC patients. Key words—Lipid metabolism, Colorectal cancer, Lipidregulating therapy, Treatment strategies, Traditional Chinese medicine Highlights—Lipid metabolism is closely associated with colorectal carcinogenesis and development, which emerges as a potential therapeutic target gradually. Besides, in view of the complexity and uncertainty of targeted lipid-regulating therapy for colorectal cancer, traditional Chinese medicine might provide novel insights, explanations and directions to the lipid-regulating therapy in colorectal cancer. INTRODUCTION Colorectal cancer (CRC) is one of the most common malignant tumors with the third morbidity and fourth mortality in the global world [1]. The etiology of CRC is unknown but closely related to the environment, heredity, lifestyle and diet [2], as well as metabolic diseases such as obesity, hyperlipidemia, hypertension and diabetes [3]. Lipid metabolism is emerging as a potential therapeutic target gradually. Besides, TCM might provide novel insights, explanations and directions to the lipid-regulating therapy. Therefore, this study reviewed and investigated the mechanism of lipid metabolism and TCM comment. LIPID METABOLIC ALTERATIONS OF TUMOR CELLS Tumor metabolism is more exuberant than that of normal cells, with obvious differences in energy metabolism such as sugar, lipid, nucleic acid and protein. Since Weinberg put forward the anaerobic glycolysis of tumor cells, researches on tumor metabolism have been deepened. Lipids play an essential role in the cellular structure and function, involved in biofilm formation, Qian-Qian Niu is with Department of Oncology, First Teaching Hospital of Tianjin University of TCM, Tianjin, 300385, China. Yuan-Hong Zhao is with Department of Oncology, First Teaching Hospital of Tianjin University of TCM, Tianjin, 300385, China. E-mail: yuanhongzh98@163.com (Corresponding author). signaling and energy supply. Lipid metabolic alterations are the key feature of tumor cells, which is mainly characterized by the enhancement of de novo synthesized fatty acid to promote early tumor progression mediated by various transcriptional factors and lipid metabolic enzymes [4]
结直肠癌(Colorectal cancer, CRC)是发病率和死亡率的主要原因之一,与脂质代谢密切相关,其中脂肪酸代谢、脂肪因子释放、血脂水平异常都是重要的致病机制。随着人们对脂质代谢认识的提高,脂质调节治疗的进展使CRC的抗肿瘤作用成为可能。然而,目前仍有许多研究空白和局限性。考虑到结直肠癌靶向调脂治疗的复杂性和不确定性,中医在“整体观念”和“辨证论治”理论方面可能具有优势。同时,合理的饮食方向、健康的生活方式、正常的血脂水平直接影响结直肠癌患者的预后。【关键词】脂质代谢;结直肠癌;脂质调节疗法;此外,鉴于结直肠癌靶向调脂治疗的复杂性和不确定性,中医药可能为结直肠癌调脂治疗提供新的见解、解释和方向。结直肠癌(Colorectal cancer, CRC)是全球最常见的恶性肿瘤之一,发病率居世界第三,死亡率居世界第四。结直肠癌的病因尚不清楚,但与环境、遗传、生活方式、饮食[3]以及肥胖、高脂血症、高血压、糖尿病[3]等代谢性疾病密切相关。脂质代谢逐渐成为潜在的治疗靶点。此外,中医可能为调脂治疗提供新的见解、解释和方向。因此,本研究对脂质代谢的机制和中医评论进行了综述和探讨。肿瘤细胞的脂质代谢变化肿瘤细胞的代谢比正常细胞更为旺盛,在糖、脂质、核酸、蛋白质等能量代谢方面存在明显差异。自Weinberg提出肿瘤细胞厌氧糖酵解以来,对肿瘤代谢的研究不断深入。脂质在细胞结构和功能中起着至关重要的作用,参与生物膜的形成。天津中医药大学第一附属医院肿瘤科,天津300385。赵元红,天津中医药大学第一附属医院肿瘤科,天津300385。E-mail: yuanhongzh98@163.com(通讯作者)。信号和能量供应。脂质代谢改变是肿瘤细胞的关键特征,主要表现为通过多种转录因子和脂质代谢酶[4]介导的从头合成脂肪酸增强促进肿瘤早期进展,同时与肿瘤细胞生长、增殖、凋亡、迁移、炎症反应和抗肿瘤耐药密切相关。脂肪细胞积聚形成的脂肪组织为机体储存能量,作为重要的内分泌器官,通过分泌大量的脂肪因子和细胞因子如肿瘤坏死因子(TNF α)、白细胞介素(IL)-6、IL-8等调节免疫和自噬[5]。此外,脂肪组织的长期炎症也可诱导结直肠癌的发生和发展[6,7]。结直肠癌和血脂水平血清游离脂肪酸(FFA)水平升高可引起氧化应激、脂质毒性或高甘油三酯血症。FFA4在结直肠癌细胞系和机制尚不清楚的动物模型中高表达。流行病学研究发现,血清脂质代谢水平与结直肠癌密切相关。高密度脂蛋白(HDL)水平升高是结直肠癌[9]的保护因素,而总胆固醇(TCHO)水平升高是结直肠癌[9]的危险因素。此外,甘油三酯(TC)目前尚不确定[5],可能与结直肠腺瘤的发生有关。结直肠癌的降脂治疗减少脂质来源限制外部脂质摄取ω-3和ω-6多不饱和脂肪酸是只能从食物中获得的必需脂肪酸。前者主要从植物油、核桃和绿色蔬菜中摄取,而后者则多见于动物脂肪中。研究结果表明,富含ω-6脂肪酸的饮食可促进炎症、心血管疾病和癌症,而ω-3脂肪酸具有抗炎作用,可抑制IL-1β、IL-6和TNF-α,降低结直肠癌的风险。最近的研究也发现,亚洲地区的CRC发病率呈上升趋势,这可能与动物脂肪摄入过量有关。 总之,保持均衡饮食,优化必需脂肪酸的摄入比例是非常重要的。CD36的过表达诱导肿瘤转移,在细胞外2药物联合治疗环境中促进脂质吸收的跨膜通道蛋白[13]也促进了抗肿瘤治疗和治愈。脂肪酸合成酶水平增高在恶性肿瘤中很常见,包括脂肪酸合成酶(FASN)、乙酰辅酶a合成酶(ACS)、ATP柠檬酸解酶(ACLY)、脂肪酸辅酶a连接酶(ACSL)和乙酰辅酶a羧化酶(ACC)[4]。FASN是目前研究最广泛的治疗靶点。几种FASN抑制剂,如花青素、C75和奥利司他,已进入临床试验。新型FASN抑制剂TVB3166[15]在结直肠癌细胞中也表现出较强的抗肿瘤活性。此外,抑制这些脂质的合成可能是治疗抗血管生成治疗耐药性的一种治疗策略。此外,研究表明,舒尼替尼后,人类乳腺癌和结肠癌细胞的进展表现出增加的脂肪酸合成,FASN抑制剂可能减轻这种生长和转移bbb。ACSL4在一些结肠腺癌中表达上调,ACSL4抑制剂可减弱肿瘤细胞[17]的增殖。甾醇调节元件结合蛋白(SREBPs)是细胞脂质稳态的关键调节因子,在结直肠癌细胞中高表达。因此,阻断srebp - 4的转录可能会限制它们的进一步增殖。此外,肝脏x激活受体(LXR)通过诱导SREBP-1c激活脂肪酸合成。而LXR逆激动剂SR9243可抑制脂质合成,促进细胞凋亡[18]。抑制脂肪酸去饱和硬脂酰辅酶a去饱和酶(SCD)催化单不饱和脂肪酸(FAs)的合成,进一步合成甘油磷脂、鞘脂和其他脂类。研究表明,SCD是导致结直肠癌患者预后不良和进展的危险因素。而白桦酸(BetA),一种SCD抑制剂,可导致结直肠癌细胞凋亡
{"title":"Therapeutic strategy in colorectal cancer based on Traditional Chinese and Western Medicine: from the lipid metabolism perspective","authors":"Qian-qian Niu, Yuanhong Zhao","doi":"10.53388/dct2021110501","DOIUrl":"https://doi.org/10.53388/dct2021110501","url":null,"abstract":"Colorectal cancer (CRC) is a major cause of morbidity and mortality and is closely associated with lipid metabolism, of which fatty acid metabolism, the release of fat factors and the abnormal level of blood lipids are all important pathogenic mechanisms. With the increasing awareness of lipid metabolism, advances in lipid-regulating therapy have made it possible for anti-tumor effect in CRC. However, there are still many research gaps and limitations. Given the complexity and uncertainty of targeted lipidregulating therapy for CRC, traditional Chinese medicine (TCM) may have a leg up when it comes to the theory of “holistic concept” and “treatment based on syndrome differentiation”. Meanwhile, proper dietary direction, healthy lifestyles, and normal serum lipid levels contribute directly to the prognosis of CRC patients. Key words—Lipid metabolism, Colorectal cancer, Lipidregulating therapy, Treatment strategies, Traditional Chinese medicine Highlights—Lipid metabolism is closely associated with colorectal carcinogenesis and development, which emerges as a potential therapeutic target gradually. Besides, in view of the complexity and uncertainty of targeted lipid-regulating therapy for colorectal cancer, traditional Chinese medicine might provide novel insights, explanations and directions to the lipid-regulating therapy in colorectal cancer. INTRODUCTION Colorectal cancer (CRC) is one of the most common malignant tumors with the third morbidity and fourth mortality in the global world [1]. The etiology of CRC is unknown but closely related to the environment, heredity, lifestyle and diet [2], as well as metabolic diseases such as obesity, hyperlipidemia, hypertension and diabetes [3]. Lipid metabolism is emerging as a potential therapeutic target gradually. Besides, TCM might provide novel insights, explanations and directions to the lipid-regulating therapy. Therefore, this study reviewed and investigated the mechanism of lipid metabolism and TCM comment. LIPID METABOLIC ALTERATIONS OF TUMOR CELLS Tumor metabolism is more exuberant than that of normal cells, with obvious differences in energy metabolism such as sugar, lipid, nucleic acid and protein. Since Weinberg put forward the anaerobic glycolysis of tumor cells, researches on tumor metabolism have been deepened. Lipids play an essential role in the cellular structure and function, involved in biofilm formation, Qian-Qian Niu is with Department of Oncology, First Teaching Hospital of Tianjin University of TCM, Tianjin, 300385, China. Yuan-Hong Zhao is with Department of Oncology, First Teaching Hospital of Tianjin University of TCM, Tianjin, 300385, China. E-mail: yuanhongzh98@163.com (Corresponding author). signaling and energy supply. Lipid metabolic alterations are the key feature of tumor cells, which is mainly characterized by the enhancement of de novo synthesized fatty acid to promote early tumor progression mediated by various transcriptional factors and lipid metabolic enzymes [4]","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70805755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
药物联合治疗
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1